Medication management
Deprescribing Mental Health Medications
A systematic, medically supervised process for reducing or stopping psychiatric medications when the risks have come to outweigh the benefits.
About this program
Deprescribing
Deprescribing is the systematic reduction or discontinuation of medications that are no longer necessary or effective — a growing focus in mental health care as awareness of polypharmacy and its complications has increased. The goal is to optimize each person’s regimen, not simply to subtract from it.
Long-term treatment often accumulates prescriptions: a medication stops working as well, another is added, and years later a person is managing a regimen no one ever planned. Deprescribing evaluates the continued necessity of each medication through collaborative decision-making — weighing symptom severity, day-to-day function, and the patient’s own preferences.
Ambrosia Behavioral Health has made deprescribing a clinical specialty, with experienced clinicians who evaluate the risks and benefits of each medication and engage patients and families in the decisions. Thorough assessment, tailored goals, and continuous monitoring run through the whole process.
Why deprescribing matters
Taking multiple psychiatric medications raises the risk of adverse drug interactions and side effects, and long-term use of some medications can lead to dependence or diminishing therapeutic returns. Cognitive and functional side effects can even work against the conditions the medications were meant to treat.
Medications can also simply stop working. The brain may adapt to a medication over time, diminishing its effects, and mental health conditions themselves evolve with stressors, trauma, and life circumstances — so a prescription that fit five years ago may no longer fit today.
How medications are reduced safely
Comprehensive review
Every medication is evaluated: why it was prescribed, whether it is still working, and what adverse effects it may be causing, alongside a thorough treatment history.
Shared decision
Clinician and patient discuss the rationale, benefits, and risks of any change together — nothing is stopped abruptly or unilaterally.
Gradual taper
Doses are reduced step by step to minimize withdrawal symptoms and the risk of relapse, often with non-pharmacological supports added in parallel.
Close monitoring
Regular follow-up appointments track mental health status throughout, and the plan is adjusted whenever symptoms call for it.
When deprescribing is considered
Deprescribing is most often considered when an original prescription has lost effectiveness over time and other medications have been layered on top — the pattern known as polypharmacy. Conditions where a careful medication review is common include:
- Schizophrenia and other psychotic disorders
- Bipolar disorder
- Anxiety, especially with long-term benzodiazepine use
- Major depressive disorder
- Substance use disorders
- Obsessive-compulsive disorder
Medications often reviewed
A deprescribing review considers the whole regimen in light of the person’s health status, preferences, and goals of care. Classes commonly evaluated include:
- Antipsychotics, first- and second-generation
- Benzodiazepines such as clonazepam and alprazolam
- SSRIs and SNRIs
- Mood stabilizers
- Gabapentin
What patients gain
- Fewer side effects and drug interactions
- A smaller daily pill burden
- A stronger voice in their own treatment decisions
- More room for therapy and non-pharmacological care
- Lower medication and healthcare costs
Ready to talk with admissions?
Admissions is available 24/7 to answer questions about mental health and substance use treatment options.